Senolytic agent

This page covers all Senolytic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Multiple targets including PI3K/Akt and p38 MAPK pathways in senescent cells.

Targets

Multiple targets including PI3K/Akt and p38 MAPK pathways in senescent cells

Marketed (1)

• Placebo followed by Fisetin · Wake Forest University Health Sciences · Gerontology / Aging-related conditions
  Fisetin is a natural flavonoid that acts as a senolytic agent, selectively eliminating senescent cells that accumulate with aging.

Patent intelligence

• senolytic agent patent landscape — aggregated cliff calendar, attackable patents, originator estates